Sign In/Register 0

We use cookies, check our Privacy Policies.

Tau (Phospho-Ser519) Antibody

Catalog No : A8067
  • Reactivity
    Human,Mouse,Rat
  • Applications
    WB,ELISA
  • Modification
    Phospho Specific
  • Source
    Polyclonal Rabbit
  • Storage and Stability
    -20°C/1 year
  • Size
    50 μl
  • Price/Quantity
    $205
  • Quantity
Details
  • Product Name
    Tau (Phospho-Ser519) Antibody
  • Description
    This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
  • Catalog No
    A8067
  • Reactivity
    Human, Mouse, Rat
  • Applications
    WB, ELISA
  • Modification
    Phospho Specific
  • Source
    Polyclonal Rabbit
  • Dilution
    Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
  • Purification
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
  • Concentration
    1 mg/ml
  • Storage and Stability
    -20°C/1 year
  • Other Name
    MAPT; MAPTL; MTBT1; TAU; Microtubule-associated protein tau; Neurofibrillary tangle protein; Paired helical filament-tau; PHF-tau
  • Molecular Weight (Da)
    78746
  • Gene Name
    MAPT
  • Protein Name
    Microtubule-associated protein tau
  • Human Gene ID
    4137
  • Human Swiss Prot No.
    P10636
  • Immunogen
    The antiserum was produced against synthesized peptide derived from human Tau around the phosphorylation site of Ser519/202. AA range:266-315
  • Specificity
    Phospho-Tau (S519) Polyclonal Antibody detects endogenous levels of Tau protein only when phosphorylated at S519.
  • Formulation
    Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.